|
Volumn 68, Issue 3, 2007, Pages 479-480
|
Choice of antipsychotic in HIV-infected patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
AMPHOTERICIN B;
ANTIRETROVIRUS AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
CHLORPROMAZINE;
CLOZAPINE;
EFAVIRENZ;
FLUCONAZOLE;
GANCICLOVIR;
HALOPERIDOL;
ITRACONAZOLE;
LORAZEPAM;
NEUROLEPTIC AGENT;
NEVIRAPINE;
OLANZAPINE;
PENICILLIN G;
RISPERIDONE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
THIORIDAZINE;
ZIDOVUDINE;
ZIPRASIDONE;
AGITATION;
AGRANULOCYTOSIS;
ANTICHOLINERGIC EFFECT;
AWARENESS;
CARDIOTOXICITY;
CLINICAL TRIAL;
COMORBIDITY;
CONSCIOUSNESS LEVEL;
CONTROLLED CLINICAL TRIAL;
CRYPTOCOCCAL MENINGITIS;
CYTOMEGALOVIRUS INFECTION;
DELIRIUM;
DEMENTIA;
DISEASE ASSOCIATION;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DRUG CHOICE;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
EXTRAPYRAMIDAL SYMPTOM;
EXTRAPYRAMIDAL SYNDROME;
HEART VENTRICLE EXTRASYSTOLE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPOKALEMIA;
HYPOMAGNESEMIA;
LONG TERM CARE;
LOW DRUG DOSE;
MANIA;
METABOLIC DISORDER;
NEUROSYPHILIS;
NEUTROPENIA;
PRIORITY JOURNAL;
PSYCHOSIS;
QT PROLONGATION;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
RECURRENT DISEASE;
SCHIZOPHRENIA;
SEDATION;
SHORT SURVEY;
SIDE EFFECT;
SYMPTOM;
UNSPECIFIED SIDE EFFECT;
|
EID: 33947714656
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/jcp.v68n0318 Document Type: Short Survey |
Times cited : (5)
|
References (34)
|